Azenta Return on Tangible Equity 2011-2025 | AZTA
Current and historical return on tangible equity values for Azenta (AZTA) over the last 10 years. Return on tangible equity can be defined as the amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity.
| Azenta Return On Tangible Equity Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Tangible Equity | Return on Tangible Equity |
| 2025-06-30 | $-0.11B | $0.86B | -12.16% |
| 2025-03-31 | $-0.07B | $0.91B | -6.76% |
| 2024-12-31 | $-0.16B | $0.93B | -15.38% |
| 2024-09-30 | $-0.17B | $0.95B | -14.23% |
| 2024-06-30 | $-0.16B | $1.06B | -12.22% |
| 2024-03-31 | $-0.15B | $1.27B | -10.59% |
| 2023-12-31 | $-0.02B | $1.35B | -1.22% |
| 2023-09-30 | $-0.01B | $1.46B | -0.84% |
| 2023-06-30 | $-0.04B | $1.62B | -1.94% |
| 2023-03-31 | $-0.05B | $1.78B | -2.08% |
| 2022-12-31 | $2.08B | $1.78B | 82.44% |
| 2022-09-30 | $2.13B | $2.67B | 94.55% |
| 2022-06-30 | $2.18B | $2.80B | 123.97% |
| 2022-03-31 | $2.22B | $2.83B | 188.55% |
| 2021-12-31 | $0.13B | $0.72B | 21.04% |
| 2021-09-30 | $0.11B | $0.67B | 19.88% |
| 2021-06-30 | $0.12B | $0.50B | 22.35% |
| 2021-03-31 | $0.09B | $0.54B | 18.08% |
| 2020-12-31 | $0.08B | $0.52B | 16.07% |
| 2020-09-30 | $0.07B | $0.55B | 14.06% |
| 2020-06-30 | $0.45B | $0.45B | 105.41% |
| 2020-03-31 | $0.44B | $0.43B | 142.60% |
| 2019-12-31 | $0.44B | $0.43B | 223.94% |
| 2019-09-30 | $0.44B | $0.40B | 560.77% |
| 2019-06-30 | $0.03B | $-0.02B | 49.64% |
| 2019-03-31 | $0.05B | $-0.03B | 32.57% |
| 2018-12-31 | $0.11B | $-0.04B | 47.16% |
| 2018-09-30 | $0.12B | $0.36B | 36.97% |
| 2018-06-30 | $0.12B | $0.33B | 40.66% |
| 2018-03-31 | $0.12B | $0.32B | 39.36% |
| 2017-12-31 | $0.06B | $0.25B | 22.26% |
| 2017-09-30 | $0.06B | $0.32B | 21.36% |
| 2017-06-30 | $0.06B | $0.30B | 20.11% |
| 2017-03-31 | $0.05B | $0.28B | 18.03% |
| 2016-12-31 | $-0.05B | $0.26B | -19.42% |
| 2016-09-30 | $-0.07B | $0.27B | -25.18% |
| 2016-06-30 | $-0.07B | $0.26B | -22.79% |
| 2016-03-31 | $-0.07B | $0.25B | -19.97% |
| 2015-12-31 | $0.01B | $0.33B | 3.08% |
| 2015-09-30 | $0.02B | $0.46B | 3.31% |
| 2015-06-30 | $0.01B | $0.46B | 1.75% |
| 2015-03-31 | $0.02B | $0.45B | 5.17% |
| 2014-12-31 | $0.02B | $0.45B | 5.09% |
| 2014-09-30 | $0.03B | $0.47B | 6.35% |
| 2014-06-30 | $0.04B | $0.48B | 7.62% |
| 2014-03-31 | $0.01B | $0.48B | 3.02% |
| 2013-12-31 | $0.01B | $0.45B | 2.19% |
| 2013-09-30 | $0.00B | $0.48B | -0.44% |
| 2013-06-30 | $0.11B | $0.45B | 23.08% |
| 2013-03-31 | $0.11B | $0.45B | 25.04% |
| 2012-12-31 | $0.13B | $0.46B | 28.36% |
| 2012-09-30 | $0.14B | $0.52B | 32.46% |
| 2012-06-30 | $0.03B | $0.40B | 8.73% |
| 2012-03-31 | $0.09B | $0.39B | 23.06% |
| 2011-12-31 | $0.11B | $0.38B | 27.33% |
| 2011-09-30 | $0.13B | $0.39B | 32.81% |
| 2011-06-30 | $0.14B | $0.45B | 37.25% |
| 2011-03-31 | $0.09B | $0.39B | 26.84% |
| 2010-12-31 | $0.09B | $0.36B | 27.19% |
| 2010-09-30 | $0.06B | $0.33B | 20.55% |
| 2010-06-30 | $0.02B | $0.30B | 7.67% |
| 2010-03-31 | $-0.02B | $0.28B | -8.26% |
| 2009-12-31 | $-0.20B | $0.26B | -72.53% |
| 2009-09-30 | $-0.23B | $0.26B | -78.62% |
| 2009-06-30 | $-0.43B | $0.27B | -135.75% |
| 2009-03-31 | $-0.41B | $0.30B | -120.17% |
| 2008-12-31 | $-0.27B | $0.34B | -73.30% |
| 2008-09-30 | $-0.24B | $0.36B | -59.87% |
| 2008-06-30 | $-0.02B | $0.38B | -4.79% |
| 2008-03-31 | $0.01B | $0.39B | 2.80% |
| 2007-12-31 | $0.13B | $0.44B | 25.68% |
| 2007-09-30 | $0.15B | $0.46B | 30.52% |
| 2007-06-30 | $0.17B | $0.57B | 35.21% |
| 2007-03-31 | $0.16B | $0.54B | 38.76% |
| 2006-12-31 | $0.06B | $0.42B | 15.89% |
| 2006-09-30 | $0.03B | $0.39B | 7.23% |
| 2006-06-30 | $0.00B | $0.33B | 0.32% |
| 2006-03-31 | $-0.02B | $0.34B | -5.20% |
| 2005-12-31 | $-0.02B | $0.32B | -7.89% |
| 2005-09-30 | $-0.01B | $0.24B | -4.03% |
| 2005-06-30 | $0.01B | $0.25B | 2.42% |
| 2005-03-31 | $0.02B | $0.25B | 7.02% |
| 2004-12-31 | $0.03B | $0.25B | 10.71% |
| 2004-09-30 | $0.02B | $0.24B | 7.67% |
| 2004-06-30 | $-0.04B | $0.23B | -22.59% |
| 2004-03-31 | $-0.09B | $0.21B | -60.75% |
| 2003-12-31 | $-0.12B | $0.20B | -102.90% |
| 2003-09-30 | $-0.19B | $0.08B | -181.91% |
| 2003-06-30 | $-0.81B | $0.09B | -628.35% |
| 2003-03-31 | $-0.80B | $0.11B | -399.50% |
| 2002-12-31 | $-0.78B | $0.13B | -321.07% |
| 2002-09-30 | $-0.72B | $0.19B | -251.75% |
| 2002-06-30 | $-0.08B | $0.37B | -25.04% |
| 2002-03-31 | $-0.06B | $0.29B | -17.67% |
| 2001-12-31 | $-0.05B | $0.30B | -13.82% |
| 2001-09-30 | $-0.03B | $0.32B | -8.50% |
| 2001-06-30 | $0.01B | $0.34B | 2.57% |
| 2001-03-31 | $0.01B | $0.34B | 2.84% |
| 2000-12-31 | $0.02B | $0.36B | 4.30% |
| 2000-09-30 | $0.01B | $0.36B | 4.12% |
| 2000-06-30 | $0.00B | $0.35B | 0.86% |
| 2000-03-31 | $0.00B | $0.33B | -0.56% |
| 1999-12-31 | $0.00B | $0.13B | -3.17% |
| 1999-09-30 | $-0.01B | $0.13B | -7.30% |
| 1999-06-30 | $-0.01B | $0.12B | -10.68% |
| 1999-03-31 | $-0.02B | $0.12B | -12.12% |
| 1998-12-31 | $-0.02B | $0.12B | -15.90% |
| 1998-09-30 | $-0.02B | $0.12B | -21.99% |
| 1998-06-30 | $-0.01B | $0.13B | -16.77% |
| 1998-03-31 | $-0.01B | $0.13B | -17.39% |
| 1997-12-31 | $-0.01B | -16.00% | |
| 1997-09-30 | $0.00B | $0.05B | -5.97% |
| 1997-06-30 | $0.00B | $0.05B | 0.00% |
| 1997-03-31 | $0.00B | $0.05B | 4.00% |
| 1996-12-31 | $0.01B | $0.05B | 12.24% |
| 1996-09-30 | $0.01B | $0.05B | 17.02% |
| 1996-06-30 | $0.01B | $0.05B | 18.08% |
| 1996-03-31 | $0.01B | $0.05B | 18.54% |
| 1995-12-31 | $0.01B | $0.04B | 19.20% |
| 1995-09-30 | $0.01B | $0.04B | 24.39% |
| 1995-06-30 | $0.00B | $0.02B | 34.78% |
| 1995-03-31 | $0.00B | $0.02B | 50.00% |
| 1994-12-31 | $0.00B | 200.00% | |
| 1994-09-30 | $0.00B | $0.00B | 100.00% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $1.410B | $0.656B |
| Azenta Inc. is a provider of life sciences solutions. The company provides reliable cold-chain sample management solutions and genomic services across areas such as drug development, clinical research and advanced cell therapies for the pharmaceutical, biotech, academic and healthcare institutions. Azenta Inc., formerly known as Brooks Automation Inc., is based in CHELMSFORD, Mass. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $48.674B | 59.39 |
| Tempus AI (TEM) | United States | $12.352B | 0.00 |
| Doximity (DOCS) | United States | $9.545B | 39.50 |
| Hims & Hers Health (HIMS) | United States | $8.883B | 72.26 |
| IRhythm Technologies (IRTC) | United States | $5.771B | 0.00 |
| Hinge Health (HNGE) | United States | $3.320B | 0.00 |
| Heartflow (HTFL) | United States | $2.981B | 0.00 |
| Privia Health (PRVA) | United States | $2.979B | 186.31 |
| Inspire Medical Systems (INSP) | United States | $2.642B | 43.71 |
| 10x Genomics (TXG) | United States | $2.078B | 0.00 |
| Enovis (ENOV) | United States | $1.787B | 9.38 |
| Omnicell (OMCL) | United States | $1.654B | 33.82 |
| Phreesia (PHR) | United States | $1.387B | 0.00 |
| Schrodinger (SDGR) | United States | $1.323B | 0.00 |
| Clover Health Investments (CLOV) | United States | $1.286B | 0.00 |
| Claritev (CTEV) | United States | $0.966B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.899B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.571B | 0.00 |
| Talkspace (TALK) | United States | $0.562B | 113.00 |
| Veradigm (MDRX) | United States | $0.536B | 0.00 |
| Evolent Health (EVH) | United States | $0.523B | 0.00 |
| Standard BioTools (LAB) | United States | $0.454B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.369B | 0.00 |
| Carlsmed (CARL) | United States | $0.328B | 0.00 |
| TruBridge (TBRG) | United States | $0.303B | 13.93 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.292B | 0.00 |
| CapsoVision (CV) | United States | $0.259B | 0.00 |
| Insight Molecular Diagnostics (IMDX) | United States | $0.243B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.201B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.195B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.175B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.174B | 0.00 |
| CareCloud (CCLD) | United States | $0.136B | 7.45 |
| EUDA Health Holdings (EUDA) | Singapore | $0.110B | 0.00 |
| Outset Medical (OM) | United States | $0.101B | 0.00 |
| Pulmonx (LUNG) | United States | $0.080B | 0.00 |
| NetraMark Holdings (AINMF) | Canada | $0.076B | 0.00 |
| American Well (AMWL) | United States | $0.066B | 0.00 |
| HeartBeam (BEAT) | United States | $0.057B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.055B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.038B | 0.00 |
| 111 (YI) | China | $0.035B | 0.00 |
| Precipio (PRPO) | United States | $0.032B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.028B | 0.00 |
| Lunai Bioworks (LNAI) | United States | $0.021B | 0.00 |
| Zhongchao (ZCMD) | China | $0.017B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.015B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.011B | 0.00 |
| Movano (MOVE) | United States | $0.010B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.009B | 0.00 |
| PROFUSA (PFSA) | United States | $0.008B | 0.00 |
| HeartSciences (HSCS) | United States | $0.008B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.002B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.002B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.001B | 0.00 |